PATENT CLAIM ANALYSIS

Application Number: 16165194
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "282000"]

Abstract:
The presently described technology provides compositions comprising aryl carboxylic acids and, for example NSAIDs, chemically conjugated to oxycodone (4,5-α-epoxy-14-hydroxy-17-methylmorphinan-6-one) to form novel prodrugs/compositions of oxycodone, including benzoates, salicylates, propionates, fenamates, and acetates, which have a decreased potential for abuse of oxycodone. The present technology also provides methods of treating patients, pharmaceutical kits and methods of synthesizing conjugates of the present technology.

Claim (Index 18):
A method for treating a patient having a disease, disorder, or condition mediated by binding of at least one opioid to one or more opioid receptors of the patient, comprising the step of selecting a patient with said disease, disorder, or condition and administering to said patient a therapeutically effective amount of at least on composition of  claim 3 .

Metadata:
- Claim Count in Document: 47.0
- Percentile: 97.0
- Lexical Diversity: 1.5102
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14952348', '15812730', '16054578', '15589158', '14956642']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.881968697687284
- 35 USC 102 Novelty (BERT): 0.6105710702543529
- Combined Prediction Score: 0.8548289349439909
- Mean Citation Score: 781.218746
- Max Citation Score: 836.9954
- Similarity Product: 474.8510061707735

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test